Cargando…
Therapeutic Interchange of Parenteral Anticoagulants: Challenges for Pharmacy and Therapeutics Committees
This is a review of key factors for pharmacy and therapeutics committees to consider when developing a therapeutic interchange (TI) program for venous thromboembolism (VTE) prophylaxis. Recent patient safety initiatives aimed at reducing the incidence of hospital-acquired VTE may increase the prescr...
Autor principal: | Amin, Alpesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060135/ https://www.ncbi.nlm.nih.gov/pubmed/27721333 http://dx.doi.org/10.3390/ph4111475 |
Ejemplares similares
-
State Approaches to Therapeutic Interchange in Community Pharmacy Settings: Legislative and Regulatory Authority
por: Vanderholm, Thomas, et al.
Publicado: (2018) -
Generic Substitutions and Therapeutic Interchanges in Hospital Pharmacies: A Qualitative Study from Western Saudi Arabia
por: Alsufyani, Manar Hassan, et al.
Publicado: (2023) -
PPIs Are Therapeutically Interchangeable and Ideal for a Managed Care Intervention Such as Therapeutic MAC
por: Crownover, Brian K.
Publicado: (2006) -
The Automatic Substitution of Biosimilars: Definitions of Interchangeability are not Interchangeable
por: Afzali, Anita, et al.
Publicado: (2021) -
Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies
por: Amin, Alpesh
Publicado: (2013)